Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
What does the future of psoriasis treatment look like?
“We have terrific drugs for psoriasis, but how can we do better?” Dr. Andrew Blauvelt asked.
News
How to manage isotretinoin’s bothersome mucocutaneous side effects
Often underappreciated is the potential for chronic dry eye and other ocular changes, Dr. John S. Barbieri said.
News
Expert discusses pros, cons of molecular tests for melanoma
Next generation sequencing allows for the generation of millions of sequencing reads that are aligned to a standard human genome, and likely...
News
How prevalent is pediatric melanoma?
As in adults, the stage correlates strongly with survival, and distant metastases carry a poor prognosis.
News
Optimal management of dysplastic nevi continues to evolve
“Misdiagnosis is more common for melanomas that have been assessed with punch and shave biopsies than with an excisional biopsy,” Dr. Benjamin...
News
Secukinumab shows benefit for hidradenitis suppurativa out to 52 weeks
“In my experience, optimizing treatment can take almost a year and I hope we will see longer controlled periods in future studies,” Dr. Alexa B....
News
More than 97K new cutaneous melanoma diagnoses expected in 2023
More than 1.3 million people in the United States live with cutaneous melanoma, and the overall 5-year survival is 93.7%.
News
Risk of infections low among kids receiving systemic meds for psoriasis, study finds
The analysis included 2,338 patients with psoriasis aged 17 years and younger who started new treatment with ustekinumab, etanercept, or...
News
Dermoscopy, other modalities for improving melanoma diagnoses reviewed
The learning curve for dermoscopy is steep, he added, and whether the technique should be considered a first-line tool or as a supplement to other...
News
Dermatopathologist reflects on the early history of melanoma
Melanoma was often regarded as a fungal infection in the early 1800s.
News
How should PRAME be used to evaluate melanocytic lesions?
One potential pitfall is that sun-damaged melanocytes may express PRAME.
News
Long-pulsed 1,064 nm Nd:YAG for nonaggressive BCC ‘effective and easy’
In the future, Dr. Arisa E. Ortiz and colleagues plan to evaluate the use of gold nanoparticles to more selectively target BCC during treatment....
News
Age-related atopic dermatitis phenotypes evaluated in study
“Improved understanding of the clinical phenotypes of AD may help guide choice of treatment and improve health outcomes,” the researchers wrote....
News
AAD unveils updated guidelines for topical AD treatment in adults
Of the 12 recommendations made for adults with AD, the work group ranked 7 as “strong” based on the evidence reviewed, and the rest as “...
News
Picosecond lasers for tattoo removal could benefit from enhancements, expert says
“If you promise someone results in 4 to 5 treatments, you’re going to have a large group of patients who are disappointed,” Dr. Omar A. Ibrahimi...